coinables

CMD Oversold and Over-Extended Below MAs 3-8% Oppty

NYSE:CMD   None
Cantel Medical Corp CMD is well oversold and over extended below short term and longer term MAs. Previous price structure allows for 3-8% bounce targets. The 200 day MA is laying right in between the 3 and 8% targets at $105.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。